+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Intravenous Solutions Market by Type (Peripheral Parenteral Nutrition, Total Parenteral Nutrition), Composition Solution (Carbohydrates, Dextran, Heparin & Trace Element), End-users - Forecast 2024-2030

  • PDF Icon

    Report

  • 187 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5454935
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Intravenous Solutions Market grew from USD 13.76 billion in 2023 to USD 14.99 billion in 2024. It is expected to continue growing at a CAGR of 9.13%, reaching USD 25.38 billion by 2030.

The composition of intravenous solutions can vary widely depending on their intended purpose, including isotonic, hypertonic, and hypotonic solutions, each tailored to achieve specific therapeutic objectives. Key constituents often include saline, dextrose, electrolytes, and sometimes vitamins or medications. Careful selection and administration of Intravenous solutions are critical for patient care in acute and chronic medical settings. Understanding the precise formulation and appropriate use of intravenous solutions is foundational to ensuring effective treatment outcomes and patient safety. The intravenous solutions market is driven by an increasing prevalence of chronic diseases, rising incidences of surgeries, and rising regulatory approvals for intravenous formulations globally. However, technical limitations of intravenous solutions and the need for skilled personnel pose a challenge to adopting intravenous solutions. Advancements and research initiatives to improve the efficiency and safety of intravenous fluids are offering lucrative growth opportunities for the Intravenous solutions market expansion.

Regional Insights

In the Americas, the intravenous solutions market is expanding, with the United States at the forefront due to its advanced healthcare facilities and the presence of leading industry players. A notable demand surge is attributed to the rising cases of chronic diseases such as cancer, diabetes, and gastrointestinal disorders. The Americas benefits from a strong focus on research and development, fostering the introduction of innovative products. The Asia-Pacific region is poised for the fastest market growth, propelled by increasing disposable incomes, expanding healthcare framework, and heightened health awareness, particularly in growing economies such as China and India. The extensive population in the Asia-Pacific region also offers vast opportunities for the intravenous solutions market expansion, supported by government efforts to improve healthcare infrastructure and implement market-friendly policies. The EMEA region maintains steady growth, with Europe having sophisticated healthcare systems, high levels of patient awareness, and stringent regulatory standards. The Middle East and Africa are projected to witness moderate growth, primarily driven by heightened healthcare infrastructure investments and a growing demand for healthcare services in Gulf Cooperation Council (GCC) countries and South Africa.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Intravenous Solutions Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Increase in the Incidence of Chronic and Acute Diseases such as Gastrointestinal Disorder, Cancer, and Neurological Diseases
  • Increasing Regulatory Approvals for Intravenous Solution Injections
  • Rise in Strategic Collaborations Between Manufacturers to Enhance their Product Portfolio

Market Restraints

  • High Cost of Maintenance of Fluids

Market Opportunities

  • Increase in Demand for Intravenous Solutions from Developing Economies
  • Improvements and New Innovations in the Products for Patient Convenience
  • Implementation of Vitamin C Intravenous for Patients with Colorectal Cancer

Market Challenges

  • Side Effects of Intravenous Fluids

Market Segmentation Analysis

  • Type: Widening use of total parenteral nutrition owing to rising nutritional and metabolic needs
  • End-Users: Rising demand from hospitals & clinics to cater to a broad spectrum of patient needs

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Intravenous Solutions Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Intravenous Solutions Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Hikma announces US launch of COMBOGESIC IV

Hikma Pharmaceuticals PLC announced the US launch of COMBOGESIC IV, an innovative opioid-free intravenous treatment that combines 1,000 mg of acetaminophen and 300 mg of ibuprofen for effective pain relief. Approved by the FDA in October 2023, this medication is intended for adult patients requiring intravenous pain management, providing an option for mild to moderate pain relief and as an adjunct for severe pain in conjunction with opioid analgesics.

Sanjivani Paranteral Limited and HAL collaborate to manufacture IV formulations and IV Sets

Sanjivani Paranteral Limited collaborated with Hindustan Antibiotics Limited, focusing on the production of intravenous (IV) formulations and sets. This strategic collaboration has led to the construction of a cutting-edge manufacturing facility with an impressive investment.

CTMUHB and Baxter partner to implement safer IV fluid administration

In response to the critical challenges surrounding intravenous (IV) fluid misadministration and its adverse impacts on patient outcomes, Cwm Taf Morgannwg University Health Board (CTMUHB) has collaborated with Baxter Healthcare to enhance IV fluid safety and adherence to NICE guidelines within their healthcare settings. The initiative includes the introduction of a prescription guide, the provision of advanced educational resources for healthcare professionals, and the implementation of visual aids such as color-coded labeling and digital storyboards to facilitate easier identification and awareness.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Intravenous Solutions Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Intravenous Solutions Market, highlighting leading vendors and their innovative profiles. These include Ajinomoto Co., Inc., Amanta Healthcare Ltd., Anhui Medipharm Co. Ltd, Axa Parenterals Ltd, B. Braun Melsungen AG, Baxter International Inc, Becton, Dickinson and Company, Enzymes Pharmaceuticals, Eurolife Healthcare Pvt. Ltd., Fresenius SE & Co. KGaA, Grifols, S.A., ICU Medical, Inc., JW Life Science Corporation, Lxir Medilabs Pvt. Ltd., Nymak Pharma Ltd., Otsuka Holdings Co., Ltd., Pfizer Inc., Salius Pharma Private Limited, Schwitz Biotech, Sichuan Kelun Pharmaceutical Co., Ltd., Soxa Formulations & Research Pvt. Ltd., Terumo Corporation, Trumac Healthcare, Varni Corporation, and Vifor Pharma Management Ltd..

Market Segmentation & Coverage

This research report categorizes the Intravenous Solutions Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type

  • Peripheral Parenteral Nutrition
  • Total Parenteral Nutrition

Composition Solution

  • Carbohydrates
  • Dextran
  • Heparin & Trace Element
  • Parenteral Lipid Emulsion
  • Single Dose Amino Acid Solution
  • Vitamins & Minerals

End-users

  • Ambulatory Surgical Centers
  • Hospitals & Clinics
  • Long-term Care Facilities
  • Specialty Clinics

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in the Incidence of Chronic and Acute Diseases such as Gastrointestinal Disorder, Cancer, and Neurological Diseases
5.1.1.2. Increasing Regulatory Approvals for Intravenous Solution Injections
5.1.1.3. Rise in Strategic Collaborations Between Manufacturers to Enhance their Product Portfolio
5.1.2. Restraints
5.1.2.1. High Cost of Maintenance of Fluids
5.1.3. Opportunities
5.1.3.1. Increase in Demand for Intravenous Solutions from Developing Economies
5.1.3.2. Improvements and New Innovations in the Products for Patient Convenience
5.1.3.3. Implementation of Vitamin C Intravenous for Patients with Colorectal Cancer
5.1.4. Challenges
5.1.4.1. Side Effects of Intravenous Fluids
5.2. Market Segmentation Analysis
5.2.1. Type: Widening use of total parenteral nutrition owing to rising nutritional and metabolic needs
5.2.2. End-Users: Rising demand from hospitals & clinics to cater to a broad spectrum of patient needs
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Intravenous Solutions Market, by Type
6.1. Introduction
6.2. Peripheral Parenteral Nutrition
6.3. Total Parenteral Nutrition
7. Intravenous Solutions Market, by Composition Solution
7.1. Introduction
7.2. Carbohydrates
7.3. Dextran
7.4. Heparin & Trace Element
7.5. Parenteral Lipid Emulsion
7.6. Single Dose Amino Acid Solution
7.7. Vitamins & Minerals
8. Intravenous Solutions Market, by End-users
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Hospitals & Clinics
8.4. Long-term Care Facilities
8.5. Specialty Clinics
9. Americas Intravenous Solutions Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Intravenous Solutions Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Intravenous Solutions Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Hikma announces US launch of COMBOGESIC IV
12.3.2. Sanjivani Paranteral Limited and HAL collaborate to manufacture IV formulations and IV Sets
12.3.3. CTMUHB and Baxter partner to implement safer IV fluid administration
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. INTRAVENOUS SOLUTIONS MARKET RESEARCH PROCESS
FIGURE 2. INTRAVENOUS SOLUTIONS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. INTRAVENOUS SOLUTIONS MARKET DYNAMICS
FIGURE 7. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 12. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. INTRAVENOUS SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. INTRAVENOUS SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. INTRAVENOUS SOLUTIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PERIPHERAL PARENTERAL NUTRITION, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PERIPHERAL PARENTERAL NUTRITION, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY DEXTRAN, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY DEXTRAN, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY HEPARIN & TRACE ELEMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY HEPARIN & TRACE ELEMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PARENTERAL LIPID EMULSION, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PARENTERAL LIPID EMULSION, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY SINGLE DOSE AMINO ACID SOLUTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY SINGLE DOSE AMINO ACID SOLUTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY VITAMINS & MINERALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY VITAMINS & MINERALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 38. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 39. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 40. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 45. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 46. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 47. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 48. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 49. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 50. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 51. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 52. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 53. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 54. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 55. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 56. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 57. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 58. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 59. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 60. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 61. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 62. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 63. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 64. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 65. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 66. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 67. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 68. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 69. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 70. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 71. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 72. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 73. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 74. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 75. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 76. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 78. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 80. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 82. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 84. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 85. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 86. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 87. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 88. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 89. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 90. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 91. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 92. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 93. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 94. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 95. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 96. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 97. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 98. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 99. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 100. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 101. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 102. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 103. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 104. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 105. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 106. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 107. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 108. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 109. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 110. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 111. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 112. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 113. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 114. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 115. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 116. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 117. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 118. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 119. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 120. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 121. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 122. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 123. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 124. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 125. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 126. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 127. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 128. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 129. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 130. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 131. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 132. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 133. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 134. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 135. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 136. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 137. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 138. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 139. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 140. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 141. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 142. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 143. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 144. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 145. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 146. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 147. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 148. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 149. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 150. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 151. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 152. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 153. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 154. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 155. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 156. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 165. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 166. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 167. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 168. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 169. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 170. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 171. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 172. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 173. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 174. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 175. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 176. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 177. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 178. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 179. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 180. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 181. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 182. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 183. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 184. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 185. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 186. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 187. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 188. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 189. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 190. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 191. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 192. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 193. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 194. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 195. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 196. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 197. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 198. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 199. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 200. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 201. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 202. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 203. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 204. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 205. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 206. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 207. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 208. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 209. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 210. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 211. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 212. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 213. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 214. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 215. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 216. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 217. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 218. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 219. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 220. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 221. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 222. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 223. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 224. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 225. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 226. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 227. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 228. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 229. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 230. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 231. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 232. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 233. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 234. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 235. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 236. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 237. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 238. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 239. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 240. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 241. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 242. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 244. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 246. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 248. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 250. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 252. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 254. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 255. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 256. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 257. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 258. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 259. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 260. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 261. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 262. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 263. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 264. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 265. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 266. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 267. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 268. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 269. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 270. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 271. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 272. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 273. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 274. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 275. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 276. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 277. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 278. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 286. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2023 (USD MILLION)
TABLE 288. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2024-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 290. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 291. INTRAVENOUS SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 292. INTRAVENOUS SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Ajinomoto Co., Inc.
  • Amanta Healthcare Ltd.
  • Anhui Medipharm Co. Ltd
  • Axa Parenterals Ltd
  • B. Braun Melsungen AG
  • Baxter International Inc
  • Becton, Dickinson and Company
  • Enzymes Pharmaceuticals
  • Eurolife Healthcare Pvt. Ltd.
  • Fresenius SE & Co. KGaA
  • Grifols, S.A.
  • ICU Medical, Inc.
  • JW Life Science Corporation
  • Lxir Medilabs Pvt. Ltd.
  • Nymak Pharma Ltd.
  • Otsuka Holdings Co., Ltd.
  • Pfizer Inc.
  • Salius Pharma Private Limited
  • Schwitz Biotech
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • Soxa Formulations & Research Pvt. Ltd.
  • Terumo Corporation
  • Trumac Healthcare
  • Varni Corporation
  • Vifor Pharma Management Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages187
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 14.99 Billion
Forecasted Market Value ( USD ) by 2030 $ 25.38 Billion
Compound Annual Growth Rate9.1%
Regions CoveredGlobal

Related Topics

Related Reports

Global Intravenous Solutions Market Size, Share & Trends Analysis Report by Product (TPN, PPN), Nutrients (Carbohydrates, Vitamins & Minerals, Single-dose Amino Acids) by Region (Asia Pacific, North America), and Segment Forecasts, 2024-2030 - Product Image

Global Intravenous Solutions Market Size, Share & Trends Analysis Report by Product (TPN, PPN), Nutrients (Carbohydrates, Vitamins & Minerals, Single-dose Amino Acids) by Region (Asia Pacific, North America), and Segment Forecasts, 2024-2030

  • Report
  • 114 Pages
  • Global
From
Global Intravenous Solutions Market Analysis & Forecast to 2024-2034 - Product Image

Global Intravenous Solutions Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Intravenous Solutions Market Report by Type (Partial Parenteral Nutrition, Total Parenteral Nutrition), Nutrients (Carbohydrates, Salts and Electrolytes, Minerals, Vitamins, Amino Acids), and Region 2024-2032 - Product Image

Intravenous Solutions Market Report by Type (Partial Parenteral Nutrition, Total Parenteral Nutrition), Nutrients (Carbohydrates, Salts and Electrolytes, Minerals, Vitamins, Amino Acids), and Region 2024-2032

  • Report
  • 141 Pages
  • Global
From
Intravenous Solutions Global Market Report 2024 - Product Image

Intravenous Solutions Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Intravenous (IV) Solutions - Global Strategic Business Report - Product Image

Intravenous (IV) Solutions - Global Strategic Business Report

  • Report
  • 487 Pages
  • Global
From

About the IV Solution Market

The IV Solution market is a segment of the medical device industry that focuses on the production and distribution of intravenous solutions. These solutions are used to deliver medications, nutrients, and other fluids directly into a patient's bloodstream. IV solutions are typically packaged in bags, bottles, or syringes and are available in a variety of concentrations and sizes. They are used in a variety of medical settings, including hospitals, clinics, and home care. The IV Solution market is highly competitive, with a wide range of products available from a variety of manufacturers. Companies in the market include Baxter International, B. Braun Melsungen AG, Fresenius Kabi, Hospira, ICU Medical, and Terumo Corporation. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.